Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Radioiodine Treatment for Thyroid Disease
source: Graves' Disease & Thyroid Foundation
year: 2014
authors: Cherie Lisa Vaz
summary/abstract:Radioiodine is a radioactive isotope of iodine. It is an antithyroid radiopharmaceutical agent used to treat patients with some of the most common types of thyroid diseases, most importantly Graves’ disease and thyroid cancer. The uptake of the radioactive iodine by thyroid tissue can also be visualized with gamma scanners and therefore we also use radioiodine for thyroid gland imaging.
How Does It Work?
Normal thyroid tissue takes up iodine from blood. Like iodine, RAI (radioactive iodine) or radioiodine is similarly taken up by thyroid cells. It is taken orally, and can be administered as a capsule or solution. The iodine is subsequently concentrated in thyroid tissue. RAI then emits beta radiation which causes thyroid cell death. It induces tissue damage, resulting in ablation of the thyroid tissue within 5 to 20 weeks. This therapy can therefore be used to treat and typically cure hyperthyroidism due to Graves’ disease and certain other causes, as well as certain types of thyroid cancer.
read more
Related Content
-
Treatment of Hyperthyroidism With Antithyroid Drugs Corrects Mild Neutropenia in Graves’ DiseaseContext: Neutropenia secondary to antit...
-
Hyperthyroidism: Should I Use Antithyroid Medicine or Radioactive Iodine?You may want to have a say in this decis...
-
Risk Factors For Developing Thyroid-Associated Ophthalmopathy Among Individuals with Graves’ DiseaseImportance: Thyroid-associated ophthalm...
-
Symptoms Strongly Drive the Consideration of Alternative Thyroid Hormone-Replacement Options in Patients With Hypoth...The standard treatment for hypothyroidis...
-
Thyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients With HyperthyroidismObjective: The purpose of this study wa...
-
Weight Gain After Treatment of Graves’ Disease in ChildrenObjective: The frequency of and risk fa...
-
Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves’ Disease By Early Initiatio...Background: Radioactive iodine (RAI) th...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
myBinder